Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation

Inclusion Criteria: * Aged 2 through 55 years on the day of enrollment "2 through 55 years" means from the day of the 2nd birthday to the day before the 56th birthday * For adults (18-55 years old) Informed consent form has been signed and dated by the participant. * For minors: Informed consent form has been signed and dated by the parent. In addition, in accordance with the Institution Ethics Committee/Institution Review Board requirements and as appropriate for the age of the participant: * participants aged 14 to 17 years are required to sign and date the informed consent form, * participants aged 10 to 13 years are required to sign and date the assent form, * for participants under 10 years, consent may be asked orally according to participant's age and ability for understanding * Receipt of one dose of Menactra® on the day of inclusion and prior to enrollment into the study, in routine practice according to the approved local product insert. Exclusion Criteria: * Participation at the time of study enrollment (or in the 4 weeks preceding the enrollment) or planned participation during the present study period in a clinical study investigating a vaccine, drug, medical device, or medical procedure.